Evidence map›Paper›PMID 34940360›Full record

ArticleBioengineering (Basel, Switzerland)2021

Metabolic and Transcriptional Changes across Osteogenic Differentiation of Mesenchymal Stromal Cells.

Thora Bjorg Sigmarsdottir, Sarah McGarrity, Adrián López García de Lomana, Aristotelis Kotronoulas, Snaevar Sigurdsson, James T Yurkovich, Ottar Rolfsson, Olafur Eysteinn Sigurjonsson

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Glucose metabolism in osteoporosis: A potential therapeutic target (Review).International journal of molecular medicine · 2026
    Review
  2. MSTNCells · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thora Bjorg SigmarsdottirSchool of Science and Engineering, Reykjavík University, 101 Reykjavik, Iceland.
Sarah McGarritySchool of Science and Engineering, Reykjavík University, 101 Reykjavik, Iceland.ORCID 0000-0002-2878-6194
Adrián López García de LomanaCenter for Systems Biology, University of Iceland, 101 Reykjavik, Iceland.ORCID 0000-0002-9748-347X
Aristotelis KotronoulasCenter for Systems Biology, University of Iceland, 101 Reykjavik, Iceland.
Snaevar SigurdssonBiomedical Center, University of Iceland, 101 Reykjavik, Iceland.ORCID 0000-0003-4860-6311
James T YurkovichDepartment of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-9403-509X
Ottar RolfssonCenter for Systems Biology, University of Iceland, 101 Reykjavik, Iceland.
Olafur Eysteinn SigurjonssonSchool of Science and Engineering, Reykjavík University, 101 Reykjavik, Iceland.ORCID 0000-0002-4968-842X
University of Iceland · ISReykjavík University · ISUniversity of California San Diego · US

Funding

Icelandic Research Fund 217005landspitali University Hospital Research Fund A-2019-065
6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) are multipotent post-natal stem cells with applications in tissue engineering and regenerative medicine. MSCs can differentiate into osteoblasts, chondrocytes, or adipocytes, with functional differences in cells during osteogenesis accompanied by metabolic changes. The temporal dynamics of these metabolic shifts have not yet been fully characterized and are suspected to be important for therapeutic applications such as osteogenesis optimization. Here, our goal was to characterize the metabolic shifts that occur during osteogenesis. We profiled five key extracellular metabolites longitudinally (glucose, lactate, glutamine, glutamate, and ammonia) from MSCs from four donors to classify osteogenic differentiation into three metabolic stages, defined by changes in the uptake and secretion rates of the metabolites in cell culture media. We used a combination of untargeted metabolomic analysis, targeted analysis of

Indexed as

gene regulatory networkglycolysismesenchymal stromal cells (MSCs)metabolic changesmetabolismmetabolitesosteogenic differentiationoxidative phosphorylation

Identifiers

PMID34940360
PMCPMC8698318
OpenAlexW4200411667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.